Navigating the acquisition of synthetic regulatory peptides requires strict adherence to analytical purity standards and verifiable manufacturing controls. This technical procurement guide outlines the biochemical profile of Selank, its primary preclinical research pathways, and the essential quality metrics required when sourcing research-grade reagents for laboratory evaluation.
Navigating the acquisition of synthetic regulatory peptides requires strict adherence to analytical purity standards and verifiable manufacturing controls. This technical procurement guide outlines the biochemical profile of Selank, its primary preclinical research pathways, and the essential quality metrics required when sourcing research-grade reagents for laboratory evaluation.
When planning a selank peptide buy for laboratory investigation, research institutions must prioritize verified chemical identity, structural purity, and lot-specific documentation. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin, modified to enhance metabolic stability in experimental settings.
Acquisition of this compound should only occur through accredited domestic suppliers capable of providing comprehensive lot-specific documentation. Validating a supplier requires reviewing reverse-phase high-performance liquid chromatography (RP-HPLC) purity analysis showing greater than 98% purity, electrospray ionization mass spectrometry (ESI-MS) for sequence confirmation, and chromogenic limulus amebocyte lysate (LAL) testing for bacterial endotoxin quantification. Investigational facilities can review verified lots via the Selank research product page to inspect complete analytical data packets prior to procurement.
Selank is a synthetic analog of the endogenously produced tetrapeptide tuftsin (Thr-Lys-Pro-Arg). By appending a Pro-Gly-Pro tripeptide sequence to the C-terminus of the tuftsin core, researchers synthesized a heptapeptide with significantly increased resistance to enzymatic degradation by serum peptidases.
The complete amino acid sequence of Selank is L-Threonyl-L-Lysyl-L-Prolyl-L-Arginyl-L-Prolyl-Glycyl-L-Proline. Its molecular formula is C33H57N11O9, with a theoretical monoisotopic molecular weight of approximately 751.9 g/mol. In vitro enzymatic assays demonstrate that the addition of the C-terminal C-terminal Pro-Gly-Pro motif protects the labile peptide bonds from rapid cleavage by carboxypeptidases and aminopeptidases, dramatically extending its half-life in culture media and tissue homogenates compared to native tuftsin.
When purchasing compounds for structural or receptor binding assays, research teams must confirm that the lyophilized peptide is free from salt impurities, trifluoroacetate (TFA) counterion residue overload, and organic solvent carryover from solid-phase peptide synthesis (SPPS). High-purity preparations ensure that observed cellular responses are attributable strictly to the peptide sequence rather than residual processing impurities. You can explore our catalog of pure sequences via the all peptides directory.
Preclinical investigation into Selank focuses primarily on its neurochemical and immunomodulatory properties in rodent and cell culture models. Unlike classical pharmacological agents that directly bind as high-affinity agonists or antagonists to primary neurotransmitter receptors, Selank acts largely as a biological response modifier and allosteric modulator.
In vitro data indicate that Selank influences gamma-aminobutyric acid (GABA) ergic neurotransmission. Experimental models evaluating recombinant GABAA receptors demonstrate that Selank can modulate receptor affinity for endogenous ligands without directly occupying the primary GABA binding site or the benzodiazepine recognition pocket. This allosteric interaction is studied in relation to its ability to modulate intracellular signaling cascades without inducing receptor down-regulation or rapid desensitization.
Additionally, preclinical rodent studies suggest that Selank influences monoaminergic systems, altering the synthesis and turnover rates of serotonin (5-HT) and dopamine in specific brain regions, including the hippocampus and prefrontal cortex. Experimental assays also reveal that Selank upregulates the expression of Brain-Derived Neurotrophic Factor (BDNF) and mRNA transcripts for its primary receptor, TrkB, in neuronal culture models. Researchers interested in broader neurobiological mechanisms can reference our neuropeptide research library.
To properly contextualize experimental designs, investigators often contrast Selank against structurally or functionally related synthetic regulatory peptides. The most prominent comparator is Semax, an ACTH(4-10) analog designed via a similar structural stabilization strategy using a Pro-Gly-Pro C-terminal extension.
While both peptides incorporate the stabilizing Pro-Gly-Pro motif, their primary mechanisms of action in preclinical literature diverge substantially. Semax research highlights its primary activity in modulating melanocortin receptors, brain-derived neurotrophic factor (BDNF) expression, and vascular endothelial growth factor (VEGF) cascades. Conversely, research involving Selank centers around GABAergic modulation, enkephalin degradation inhibition, and cytokine modulation.
In comparative preclinical models evaluating tissue repair and cellular protection, researchers also frequently compare neuropeptides with systemic regenerative signaling compounds like BPC-157. While BPC-157 regulates focal adhesion kinase and VEGFR2 pathways involved in angiogenesis and tissue restoration, Selank operates predominantly through central neurochemical and gene expression networks. Understanding these distinct pathways allows laboratories to construct precise multi-target experimental matrices within our research hub.
The execution of a high-purity selank peptide buy requires strict adherence to quantitative quality control metrics. Synthetic peptides produced via Solid-Phase Peptide Synthesis (SPPS) naturally accumulate minor impurities, including deletion sequences, truncated fragments, diastereomers, and incompletely deprotected side chains. Unregulated suppliers often sell material without adequate testing, introducing variables that invalidate experimental data.
PX1 Research enforces stringent analytical protocols for every production lot. Purity must be verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) utilizing a C18 stationary phase and a gradient mobile phase (typically water/acetonitrile with 0.1% TFA). A compliant lot must demonstrate a sharp, symmetric principal peak representing >98% total peak area at 214 nm UV detection.
Identity verification requires high-resolution Mass Spectrometry—specifically Electrospray Ionization (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF). The observed molecular mass must match the theoretical monoisotopic mass of 751.9 Da within strict instrument tolerance limits (+/- 0.5 Da).
Finally, because Selank is routinely evaluated in cell culture and animal models, endotoxin contamination poses a critical confounder. Bacterial lipopolysaccharides (LPS) trigger inflammatory signaling pathways that obscure biological outcomes. Every PX1 Research lot undergoes chromogenic LAL testing to guarantee endotoxin levels remain below 0.1 EU/mg, suitable for sensitive in vitro and preclinical research applications.
Proper handling procedures are essential to maintain the structural integrity of Selank upon receipt in the laboratory. Lyophilized peptide cakes should arrive sealed under inert gas atmosphere and stored at -20°C or -80°C for long-term stability. Under sub-zero desiccated conditions, lyophilized Selank remains stable for up to 24 months without significant degradation.
When preparing the peptide for experimental use, the vial should be allowed to equilibrate to room temperature inside a desiccator before opening to prevent atmospheric moisture condensation on the cake. Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) for multi-use laboratory assays or sterile 0.9% Normal Saline / Phosphate-Buffered Saline (PBS) for sensitive cell culture procedures.
Gently direct the reconstituting solvent down the glass wall of the vial rather than splashing directly onto the lyophilized powder. Swirl the container gently; vigorous vortexing or mechanical agitation must be avoided, as shear forces can induce peptide aggregation or denaturation. Detailed guidelines on solvent selection and concentration math can be reviewed in our peptide reconstitution guide.
In laboratory settings, Selank serves as a valuable tool for investigating peptide-mediated gene regulation and peptidase interactions. Preclinical rodent models indicate that Selank inhibits enkephalin-degrading enzymes, specifically neutral endopeptidase (NEP) and aminopeptidase N (APN), in blood plasma and brain tissue homogenates. By slowing down the cleavage of endogenous enkephalins, Selank indirectly modulates opioid-mediated signaling pathways without binding directly to mu, delta, or kappa opioid receptors.
Cellular biology studies utilize Selank to examine immune-neural cross-talk. Research demonstrates that Selank alters the mRNA expression levels of interleukin-6 (IL-6) and other inflammatory cytokines in primary leukocyte cultures. Furthermore, gene expression profiling assays in rodent brain tissue reveal rapid changes in the transcription of genes involved in neurotransmission, chromatin remodeling, and cytoskeletal dynamics following peptide exposure.
Institutional laboratories requiring bulk quantities for extensive multi-phase animal studies or high-throughput screening assays can establish standardized supply chains through our dedicated wholesale procurement program.
When searching to execute a selank peptide buy, research procurement officers are often confronted with vast price disparities across online vendors. These disparities directly reflect differences in manufacturing standards, analytical verification, and quality assurance controls.
Overseas manufacturers frequently utilize low-cost synthesis protocols, skipping post-synthesis preparative HPLC purification or skipping crucial endotoxin removal steps. Furthermore, middleman vendors often present single static Certificates of Analysis (COA) generated years prior, applying them across entirely different batch syntheses. Using unverified material introduces significant risks of experimental error, cytotoxicity in cell culture, and batch-to-batch variability.
PX1 Research operates under strict domestic quality control frameworks. Every batch synthesized in cGMP-compliant US facilities undergoes independent testing at an accredited ISO 17025 laboratory. Every vial dispatched from our California and Arizona logistics centers features full lot traceability, guaranteeing that the analytical data provided corresponds precisely to the physical material delivered to your benchtop.
What is the purity level of Selank offered by PX1 Research?
PX1 Research supplies Selank at a minimum purity of 98% as determined by reverse-phase HPLC. Every lot includes an official, downloadable Certificate of Analysis detailing HPLC chromatography, mass spectrometry confirmation, and endotoxin assay results.
How should lyophilized Selank be stored upon delivery?
Lyophilized Selank should be stored at -20°C for short-to-medium-term storage (up to 12 months) or at -80°C for long-term storage (up to 24 months). Protect the peptide from exposure to light and atmospheric moisture.
What solvent is recommended for reconstituting Selank for in vitro assays?
For standard laboratory research, sterile reconstituted solutions can be prepared using 0.9% sterile saline, Phosphate-Buffered Saline (PBS, pH 7.4), or sterile Bacteriostatic Water depending on the specific requirements of the cellular assay or model system.
What is the molecular sequence and weight of Selank?
Selank is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It has a molecular formula of C33H57N11O9 and a molecular mass of 751.9 g/mol.
Are endotoxin levels tested for each lot of Selank?
Yes. Every production lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing at an independent ISO 17025 lab to verify that bacterial endotoxin levels remain below 0.1 EU/mg.
How does Selank differ structurally from Semax?
Selank is an analog of the human immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a C-terminal Pro-Gly-Pro extension. Semax is an analog of ACTH(4-10) with the same Pro-Gly-Pro tail. Though both utilize the tripeptide extension for metabolic stabilization, their sequence cores and target pathways differ.
Can Selank be provided in bulk quantities for institutional research?
Yes, PX1 Research offers custom batch sizes, bulk quantity pricing, and dedicated supply agreements for university, biotechnology, and institutional research laboratories through our wholesale account portal.
Does PX1 Research provide human administration protocols?
No. PX1 Research exclusively supplies research-grade compounds strictly for laboratory in vitro and preclinical animal research. No clinical, therapeutic, or human use protocols are provided.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.